BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28127835)

  • 1. Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
    Steck AK; Larsson HE; Liu X; Veijola R; Toppari J; Hagopian WA; Haller MJ; Ahmed S; Akolkar B; Lernmark Å; Rewers MJ; Krischer JP;
    Pediatr Diabetes; 2017 Dec; 18(8):794-802. PubMed ID: 28127835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Metabolic Outcomes in Children Diagnosed with Type 1 Diabetes Through Research Screening (Diabetes Autoimmunity Study in the Young [DAISY]) Versus in the Community.
    Chan CL; Taki I; Dong F; Hoffman M; Norris JM; Klingensmith G; Rewers MJ; Steck AK
    Diabetes Technol Ther; 2015 Sep; 17(9):649-56. PubMed ID: 26317880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Associated With the Decline of C-Peptide in a Cohort of Young Children Diagnosed With Type 1 Diabetes.
    Steck AK; Liu X; Krischer JP; Haller MJ; Veijola R; Lundgren M; Ahmed S; Akolkar B; Toppari J; Hagopian WA; Rewers MJ; Elding Larsson H
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1380-e1388. PubMed ID: 33035311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels.
    Fredheim S; Johannesen J; Johansen A; Lyngsøe L; Rida H; Andersen ML; Lauridsen MH; Hertz B; Birkebæk NH; Olsen B; Mortensen HB; Svensson J;
    Diabetologia; 2013 May; 56(5):995-1003. PubMed ID: 23389397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up.
    Elding Larsson H; Vehik K; Bell R; Dabelea D; Dolan L; Pihoker C; Knip M; Veijola R; Lindblad B; Samuelsson U; Holl R; Haller MJ; ; ; ; ;
    Diabetes Care; 2011 Nov; 34(11):2347-52. PubMed ID: 21972409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
    Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
    Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Long-term HbA1c in 7,961 Children and Young Adults in the Australasian Diabetes Data Network.
    Clapin HF; Earnest A; Colman PG; Davis EA; Jefferies C; Anderson K; Chee M; Bergman P; de Bock M; Kao KT; Fegan PG; Holmes-Walker DJ; Johnson S; King BR; Mok MT; Narayan K; Peña Vargas AS; Sinnott R; Wheeler BJ; Zimmermann A; Craig ME; Couper JJ;
    Diabetes Care; 2022 Dec; 45(12):2918-2925. PubMed ID: 36749868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of DKA Incidence and Age-Specific Clinical Characteristics in Children Diagnosed With Type 1 Diabetes in the TEDDY Study.
    Jacobsen LM; Vehik K; Veijola R; Warncke K; Toppari J; Steck AK; Gesualdo P; Akolkar B; Lundgren M; Hagopian WA; She JX; Rewers M; Ziegler AG; Krischer JP; Larsson HE; Haller MJ;
    Diabetes Care; 2022 Mar; 45(3):624-633. PubMed ID: 35043162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes Predicts Poor Long-term Glycemic Control.
    Duca LM; Wang B; Rewers M; Rewers A
    Diabetes Care; 2017 Sep; 40(9):1249-1255. PubMed ID: 28667128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.
    Thrailkill KM; Moreau CS; Swearingen C; Rettiganti M; Edwards K; Morales AE; Kemp SF; Frindik JP; Fowlkes JL
    Diabetes Technol Ther; 2011 Oct; 13(10):1023-30. PubMed ID: 21718094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
    Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
    Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
    Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
    Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.
    Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB
    Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
    Quattrin T; Haller MJ; Steck AK; Felner EI; Li Y; Xia Y; Leu JH; Zoka R; Hedrick JA; Rigby MR; Vercruysse F;
    N Engl J Med; 2020 Nov; 383(21):2007-2017. PubMed ID: 33207093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 19. Is diabetic ketoacidosis a good predictor of 5-year metabolic control in children with newly diagnosed type 1 diabetes?
    Emilia K; Aneta S; Barbara M; Małgorzata J; Aleksandra H; Paulina B; Agnieszka S
    BMC Endocr Disord; 2021 Nov; 21(1):218. PubMed ID: 34727899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?
    Smith LB; Liu X; Johnson SB; Tamura R; Elding Larsson H; Ahmed S; Veijola R; Haller MJ; Akolkar B; Hagopian WA; Rewers MJ; Krischer J; Steck AK;
    Pediatr Diabetes; 2018 Aug; 19(5):1025-1033. PubMed ID: 29577538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.